Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Clinical trial NCT00755976 · COMPLETED

Trial details

NCT number: NCT00755976
Sponsor: Cancer Trials Ireland
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2007-08-01
Primary completion: 2010-05-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.